Enhancing vaccine safety capacity globally: a lifecycle perspective

Chen, Robert T.; Shimabukuro, Tom T.; Martin, David B.; Zuber, Patrick L.F.; Weibel, Daniel M.; Sturkenboom, Miriam

doi:10.1016/j.vaccine.2015.06.073

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Enhancing vaccine safety capacity globally: a lifecycle perspective

Published Date:

Oct 01 2015

Publisher's site:

http://dx.doi.org/10.1016/j.vaccine.2015.06.073 New Site Icon

Source:

Vaccine. 33(0 4):D46-D54

Language:

English

[PDF-313.32 KB]

Details:

Alternative Title:

Vaccine

Personal Author:

Chen, Robert T. ; Shimabukuro, Tom T. ; Martin, David B. ; Zuber, Patrick L.F. ; Weibel, Daniel M. ; ... More ▼

Description:

Major vaccine safety controversies have arisen in several countries beginning in the last decades of 20th century. Such periodic vaccine safety controversies are unlikely to go away in the near future as more national immunization programs mature with near elimination of target vaccine-preventable diseases that result in relative greater prominence of adverse events following immunizations, both true reactions and temporally coincidental events. There are several ways in which vaccine safety capacity can be improved to potentially mitigate the impact of future vaccine safety controversies. This paper aims to take a "lifecycle" approach, examining some potential pre- and post-licensure opportunities to improve vaccine safety, in both developed (specifically U.S. and Europe) and low- and middle-income countries.

Subject:

[+]

Pubmed ID:

26433922

Pubmed Central ID:

PMC4663114

Document Type:

Journal Article

Funding:

001/World Health Organization/International ; CC999999/Intramural CDC HHS/United States ;

Place as Subject:

United States

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	nihms732969.nxml	text/xml
	nihms732969f1.gif	image/gif
	nihms732969f1.jpg	image/jpeg

No Related Documents.

You May Also Like:

Hospital-based collaboration for epidemiological investigation of vaccine safety: a potential solution for low and middle-income countries?

Personal Author:

Izurieta, Hector S.; Moro, Pedro; Chen, Robert T.;

Published Date:

October 21 2017

Source:

Vaccine. 36(3):345-346

File Type:

[PDF - 40.99 KB]
CDC’s strategic framework for global immunization, 2016–2020

Corporate Authors:

Centers for Disease Control and Prevention (U.S.). Center for Global Health (U.S.). Global Immunization Division..

Published Date:

May 2016

Description:

• Vision and Mission• Foreword• Overview• Background• Strategic Framework Goals, Priorities, and Objectives:o GOAL 1: Control, eliminate, or eradicate vaccine-preventable diseases to reduce death and disability globallyo GOAL 2: Strengthen ...

File Type:

[PDF - 2.18 MB]
CDC’s strategic framework for global immunization, 2016-2020

Published Date:

11/13/2015

Description:

cdc_global_immunization_strategic_framework.pdf

File Type:

[PDF - 3.97 MB]
Global Disease Detection—Achievements in Applied Public Health Research, Capacity Building, and Public Health Diplomacy, 2001–2016

Personal Author:

Rao, Carol Y.; Goryoka, Grace W.; Henao, Olga L.; Clarke, Kevin R.; Salyer, Stephanie J.; Montgomery, Joel M.;

Published Date:

Nov 2017

Source:

Emerg Infect Dis. 23(Suppl 1):S138-S146.

Description:

The Centers for Disease Control and Prevention has established 10 Global Disease Detection (GDD) Program regional centers around the world that serve as centers of excellence for public health research on emerging and reemerging infectious diseases. ...

File Type:

[PDF - 1.28 MB]
Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future

Personal Author:

Patel, Manish; Cochi, Stephen;

Published Date:

Jul 01 2017

Source:

J Infect Dis. 2017; 216(Suppl 1):S1-S8.

Description:

The Global Commission for the Certification of the Eradication of Poliomyelitis certified the eradication of type 2 poliovirus in September 2015, making type 2 poliovirus the first human pathogen to be eradicated since smallpox. The eradication of ty...

File Type:

[PDF - 1.65 MB]